RAC1 and pancreatic neoplasm: In our hands, EHT-1864, which was previously shown to interfere with Rac1 nucleotide exchange [32], did not inhibit Rac1 activation in CD18/HPAF pancreatic cancer cells following EGF stimulation, as shown in Supplementary Figure 1A.